These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 6752069

  • 1. Combination of misonidazole and m-AMSA: effects on radiation sensitivity and toxicity in E. coli.
    Roberts PB.
    Int J Radiat Biol Relat Stud Phys Chem Med; 1982 Aug; 42(2):173-83. PubMed ID: 6752069
    [Abstract] [Full Text] [Related]

  • 2. Enhanced killing of mammalian cells by radiation combined with m-AMSA.
    Roberts PB, Millar BC.
    Br J Cancer; 1980 Nov; 42(5):684-91. PubMed ID: 6893934
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical activity of m-Amsa and the combination of m-Amsa with cytosine arabinoside].
    Weil M, Auclerc MF, Schaison G, Auclerc G, Daubrisson A, Degos L, Caro J, Marty M, Jacquillat GI.
    Nouv Presse Med; 1982 Oct 09; 11(39):2911-4. PubMed ID: 6755389
    [Abstract] [Full Text] [Related]

  • 5. Misonidazole and MTDQ in combination: cytotoxic and radiosensitizing properties in hypoxic mammalian cells.
    Astor M, Hall EJ.
    Br J Cancer; 1979 May 09; 39(5):510-5. PubMed ID: 486306
    [Abstract] [Full Text] [Related]

  • 6. Phase I evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) by a weekly iv dose schedule.
    Woodcock TM, Schneider RJ, Young CW.
    Cancer Treat Rep; 1980 Jan 09; 64(1):53-5. PubMed ID: 6892893
    [Abstract] [Full Text] [Related]

  • 7. The effect of misonidazole as a hypoxic radiosensitizer at low dose.
    Palcic B, Faddegon B, Skarsgard LD.
    Radiat Res; 1984 Nov 09; 100(2):340-7. PubMed ID: 6494445
    [Abstract] [Full Text] [Related]

  • 8. Intrathecally administered m-AMSA in the rhesus monkey.
    Gormley P, Riccardi R, O'Neill D, Poplack D.
    Cancer Drug Deliv; 1984 Nov 09; 1(2):101-7. PubMed ID: 6549572
    [Abstract] [Full Text] [Related]

  • 9. Phase I-II study of m-AMSA administered as a continuous infusion.
    Micetich KC, Zwelling LA, Gormley P, Young RC.
    Cancer Treat Rep; 1982 Oct 09; 66(10):1813-7. PubMed ID: 6897013
    [Abstract] [Full Text] [Related]

  • 10. Modification of the action of misonidazole. III. The effect of diamide on toxicity and radiosensitization.
    Skov KA, Palcic B, Skarsgard LD.
    Int J Radiat Biol Relat Stud Phys Chem Med; 1981 Oct 09; 40(4):335-45. PubMed ID: 6975248
    [Abstract] [Full Text] [Related]

  • 11. Skin sensitization by misonidazole: a demonstration of uniform mild hypoxia.
    Stewart FA, Denekamp J, Randhawa VS.
    Br J Cancer; 1982 Jun 09; 45(6):869-77. PubMed ID: 7093121
    [Abstract] [Full Text] [Related]

  • 12. Toxicity of 4'-(9-acridinylamino)methanesulfon-m-anisidide in exponential- and plateau-phase Chinese hamster cell cultures.
    Wilson WR, Giesbrecht JL, Hill RP, Whitmore GF.
    Cancer Res; 1981 Jul 09; 41(7):2809-16. PubMed ID: 6894713
    [Abstract] [Full Text] [Related]

  • 13. Misonidazole in fractionated radiotherapy: are many small fractions best?
    Denekamp J, McNally NJ, Fowler JF, Joiner MC.
    Br J Radiol; 1980 Oct 09; 53(634):981-90. PubMed ID: 7426922
    [Abstract] [Full Text] [Related]

  • 14. Cardiac abnormalities after AMSA administration.
    Steinherz LJ, Steinherz PG, Mangiacasale D, Tan C, Miller DR.
    Cancer Treat Rep; 1982 Mar 09; 66(3):483-8. PubMed ID: 6949643
    [Abstract] [Full Text] [Related]

  • 15. The effect on the Km for radiosensitization at 0 degree C of thiol depletion by diethylmaleate pretreatment: quantitative differences found using the radiation sensitizing agent misonidazole or oxygen.
    Koch CJ, Stobbe CC, Bump EA.
    Radiat Res; 1984 Apr 09; 98(1):141-53. PubMed ID: 6718689
    [Abstract] [Full Text] [Related]

  • 16. Misonidazole cytotoxicity in vivo: a comparison of large single doses with smaller doses and extended contact of the drug with tumor cells.
    Conroy PJ, Sutherland RM, Passalacqua W.
    Radiat Res; 1980 Jul 09; 83(1):169-89. PubMed ID: 7394163
    [No Abstract] [Full Text] [Related]

  • 17. Enhancement of the action of alkylating agents by single high, or chronic low doses of misonidazole.
    McNally NJ, Hinchliffe M, de Ronde J.
    Br J Cancer; 1983 Aug 09; 48(2):271-8. PubMed ID: 6882665
    [Abstract] [Full Text] [Related]

  • 18. Cell-cycle-stage specificity of 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) and interaction with ionizing radiation in mammalian cell cultures.
    Wilson WR, Whitmore GF.
    Radiat Res; 1981 Jul 09; 87(1):121-36. PubMed ID: 7019954
    [No Abstract] [Full Text] [Related]

  • 19. The effects of misonidazole during continuous low dose rate irradiation.
    Fu KK, Hurst S, Begg AC, Brown JM.
    Cancer Clin Trials; 1980 Jul 09; 3(3):257-65. PubMed ID: 7438323
    [Abstract] [Full Text] [Related]

  • 20. In vitro inhibition of misonidazole toxicity and melphalan chemopotentiation by metyrapone.
    Millar BC, Jinks S.
    Br J Radiol; 1983 Mar 09; 56(663):201-6. PubMed ID: 6824844
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.